Ganoderma lucidum mediates microglial polarization and ameliorates experimental autoimmune encephalomyelitis by reducing oxidative stress and inhibiting NF-κB/STAT3 pathway. The gene discussed is NFKB1; the disease is experimental autoimmune encephalomyelitis.